Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) as Therapeutical Strategy for Negative Symptoms in Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating transcranial direct current stimulation for negative symptoms in schizophrenia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: University of Sao Paulo | Conditions: Transcranial Direct Current Stimulation, Schizophrenia | Phase 2 | Status: WITHDRAWN